Cross-border Focus Opportunity to pitch cross-border life science and healthcare solutions that enable US-based companies to expand into China/Asia, highlighting regulatory navigation, market access, and local partnerships.

Early Stage Funding Target seed to Series A opportunities with 250K to 1M checks, ideal for presenting pilots, proof-of-concept programs, and initial clinical or regulatory milestones to de-risk investment.

Strategic Partnerships Position as a gateway to government and VC follow-on funding in China, offering co-investment credibility and access to additional capital networks for portfolio companies.

Small Team, Niche Network Leverage intimate founder-level engagement and a tight signaling channel to tailor outreach, built on a focused life science/healthcare thesis and proximity to Asia market entry.

Competitive Positioning Differentiate from larger funds by emphasizing agility, cross-border expertise, and lower friction for deal screening as there is no apply fee, aligning with founders seeking streamlined introductions and fast feedback.